check_circleStudy Completed
Hemophilia A
Bayer Identifier:
17653
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Retrospective study in Chinese pediatric hemophilia A patients with rFⅧ contained regular prophylaxis
Trial purpose
To assess and describe real-life treatment choices for rFⅧ contained regular prophylaxis/bleeding prevention treatment in pediatric hemophilia patients in China (2007-2013)
Key Participants Requirements
Sex
MaleAge
2 - 18 YearsTrial summary
Enrollment Goal
181Trial Dates
October 2014 - July 2015Phase
N/ACould I Receive a placebo
NoProducts
Kogenate FS (Recombinant Factor VIII, BAY14-2222)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, China |
Primary Outcome
- Duration of regular prophylaxisdate_rangeTime Frame:Up to 1.5 yearsenhanced_encryptionNoSafety Issue:
- Prophylaxis infusion dosedate_rangeTime Frame:Up to 1.5 yearsenhanced_encryptionNoSafety Issue:
- Percentage of rFVIII usage in prophylaxisdate_rangeTime Frame:Up to 1.5 yearsenhanced_encryptionNoSafety Issue:
Secondary Outcome
- Bleeding frequencydate_rangeTime Frame:Up to 1.5 yearsenhanced_encryptionNoSafety Issue:
- Joint radiographic scoredate_rangeTime Frame:Up to 1.5 yearsenhanced_encryptionNoSafety Issue:
- Joint physical examination scoredate_rangeTime Frame:Up to 1.5 yearsenhanced_encryptionNoSafety Issue:
- Quality of life by questionnairedate_rangeTime Frame:Up to 1.5 yearsenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
Biological/VaccineTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A